These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38939971)

  • 1. The readiness of malaria services and uptake of intermittent preventive treatment in pregnancy in six sub-Saharan countries.
    Xu X; Liang D; Zhao J; Mpembeni R; Olenja J; Yam EL; Huang J
    J Glob Health; 2024 Jun; 14():04112. PubMed ID: 38939971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kombila M
    BMC Pregnancy Childbirth; 2013 Feb; 13():52. PubMed ID: 23442536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
    Yaya S; Kota K; Buh A; Bishwajit G
    BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.
    Noguchi L; Grenier L; Kabue M; Ugwa E; Oyetunji J; Suhowatsky S; Onguti B; Orji B; Whiting-Collins L; Adetiloye O
    Malar J; 2020 Jan; 19(1):51. PubMed ID: 31996209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya.
    Hill J; Dellicour S; Bruce J; Ouma P; Smedley J; Otieno P; Ombock M; Kariuki S; Desai M; Hamel MJ; ter Kuile FO; Webster J
    PLoS One; 2013; 8(6):e64913. PubMed ID: 23798997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana.
    Amoako BK; Anto F
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):105. PubMed ID: 33530957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
    Mbonye AK; Yanow S; Birungi J; Magnussen P
    BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
    Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
    BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the impact of availability and readiness of malaria services on uptake of intermittent preventive treatment in pregnancy (IPTp) provided during ANC visits in Tanzania.
    Bajaria S; Festo C; Mrema S; Shabani J; Hertzmark E; Abdul R
    Malar J; 2019 Jul; 18(1):229. PubMed ID: 31288835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based strategies to increase coverage of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in sub-Saharan Africa: a systematic review, meta-analysis, meta-ethnography, and economic assessment.
    Koita K; Kayentao K; Worrall E; Van Eijk AM; Hill J
    Lancet Glob Health; 2024 Sep; 12(9):e1456-e1469. PubMed ID: 39151981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of referral by community health workers on the uptake of intermittent preventive treatment of Malaria in pregnancy in Ohaukwu, Ebonyi State, Nigeria.
    Orji BC; Bryce E; Odio B; Onuoha HE; Njoku E; Anoke C; Ugwa E; Enne J; Oniyire A; Otolorin E; Afolabi K; Ogbulafor NC; Oliveras E
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):599. PubMed ID: 35896992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial distribution and determinants of intermittent preventive treatment for malaria during pregnancy: a secondary data analysis of the 2019 Ghana malaria indicators survey.
    Ndayishimiye JC; Teg-Nefaah Tabong P
    BMC Pregnancy Childbirth; 2024 May; 24(1):379. PubMed ID: 38769513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda.
    Sangaré LR; Stergachis A; Brentlinger PE; Richardson BA; Staedke SG; Kiwuwa MS; Weiss NS
    PLoS One; 2010 Nov; 5(11):e15066. PubMed ID: 21124732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.